{"entity":{"id":"2020-biolabs","kind":"company","name":"20/20 BioLabs","aka":["20/20 GeneSystems"],"tldr":"A Maryland laboratory company that sells OneTest, a low-cost blood test using a panel of protein tumour markers.","summary":"20/20 BioLabs, formerly 20/20 GeneSystems, runs a CLIA/CAP laboratory in Gaithersburg, Maryland, and offers OneTest for Cancer as a laboratory-developed test, stating that it has not received FDA De Novo authorisation or premarket approval.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://www.2020biolabs.com/"}],"tags":[],"related":[],"cancers":[],"sections":["early-detection","diagnostics"],"technologies":["mced","proteomics"],"targets":[],"drugs":["onetest"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Gaithersburg, MD","country":"US","companyType":"diagnostics","website":"https://www.2020biolabs.com/","ticker":"AIDX","stage":"public","investors":[],"funding":[]},"route":"/companies/2020-biolabs/","neighbours":{"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"},{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"}],"technology":[{"id":"mced","kind":"technology","name":"Multi-cancer early detection (MCED)","route":"/technologies/mced/"},{"id":"proteomics","kind":"technology","name":"Proteomics & phosphoproteomics","route":"/technologies/proteomics/"}],"drug":[{"id":"onetest","kind":"drug","name":"OneTest for Cancer","route":"/drugs/onetest/"}]}}